Effectiveness of doxycycline in the negativization of viral replication in COVID-19. Randomized Phase II clinical trial.
INDEPENDENT CLINICAL TRIAL
Clinical trial information
- Promoter: ALEJANDRO OTERO PUBLIC FOUNDATION FOR BIOSANITARY RESEARCH OF EASTERN ANDALUCIA (FIBAO)
- Phase: II
- Execution start: 04/12/2020
- End of execution: 31/12/2021
- IP: NATALIA CHUECA PORCUNA